{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:06:02Z","timestamp":1793675162486,"version":"4.5.1"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","award":["CRA\/ SCR\/2019\/1"],"award-info":[{"award-number":["CRA\/ SCR\/2019\/1"]}],"id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008700","name":"Centre International de Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.breast.2022.04.003","type":"journal-article","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T23:36:07Z","timestamp":1650324967000},"page":"85-99","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":325,"special_numbering":"C","title":["Global guidelines for breast cancer screening: A systematic review"],"prefix":"10.1016","volume":"64","author":[{"given":"Wenhui","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youlin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2022.04.003_bib1","unstructured":"Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Available at: https:\/\/gco.iarc.fr\/today\/. [accessed 2021-05-01]."},{"key":"10.1016\/j.breast.2022.04.003_bib2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S1470-2045(15)00128-X","article-title":"Effect of mammographic screening from age 40 years on breast cancer mortality in the UK Age trial at 17 years' follow-up: a randomised controlled trial","volume":"16","author":"Moss","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.breast.2022.04.003_bib64","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/M15-0969","article-title":"Effectiveness of breast cancer screening: systematic review and meta-analysis to update the 2009 US Preventive Services Task Force recommendation","volume":"164","author":"Nelson","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.breast.2022.04.003_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1158\/1055-9965.EPI-15-0803","article-title":"Impact of screening on breast cancer mortality: the UK program 20 Years on","volume":"25","author":"Massat","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.breast.2022.04.003_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/jama.2017.19130","article-title":"Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012","volume":"319","author":"Plevritis","year":"2018","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.breast.2022.04.003_bib6","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1206809","article-title":"Effect of three decades of screening mammography on breast-cancer incidence","volume":"367","author":"Bleyer","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.breast.2022.04.003_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"U.S. Preventive services Task Force. Screening for breast cancer: U.S. Preventive services Task Force recommendation statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.breast.2022.04.003_bib8","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"issue":"5","key":"10.1016\/j.breast.2022.04.003_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/jjco\/hyw008","article-title":"The Japanese guidelines for breast cancer screening","volume":"46","author":"Hamashima","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.breast.2022.04.003_bib10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.breast.2016.08.002","article-title":"Overview of guidelines on breast screening: why recommendations differ and what to do about it","volume":"31","author":"J\u00f8rgensen","year":"2017","journal-title":"Breast"},{"issue":"10","key":"10.1016\/j.breast.2022.04.003_bib11","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1002\/cam4.3898","article-title":"A systematic review of recommendations on screening strategies for breast cancer due to hereditary predisposition: who, When, and How?","volume":"10","author":"Cai","year":"2021","journal-title":"Cancer Med"},{"issue":"2","key":"10.1016\/j.breast.2022.04.003_bib12","first-page":"219","article-title":"Quality assessment of global breast cancer screening guidelines","volume":"42","author":"Li","year":"2021","journal-title":"Zhonghua Liuxingbingxue Zazhi"},{"issue":"18","key":"10.1016\/j.breast.2022.04.003_bib13","doi-asserted-by":"crossref","first-page":"E839","DOI":"10.1503\/cmaj.090449","article-title":"Agree II: advancing guideline development, reporting and evaluation in health care","volume":"182","author":"Brouwers","year":"2010","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.breast.2022.04.003_bib14","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jclinepi.2017.12.009","article-title":"Systematic review of current guideline appraisals performed with the Appraisal of Guidelines for Research & Evaluation II instrument-a third of AGREE II users apply a cut-off for guideline quality","volume":"95","author":"Hoffmann-E\u00dfer","year":"2018","journal-title":"J Clin Epidemiol"},{"issue":"2","key":"10.1016\/j.breast.2022.04.003_bib15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1378\/chest.12-2005","article-title":"Quality assessment of asthma clinical practice guidelines: a systematic appraisal","volume":"144","author":"Acu\u00f1a-Izcaray","year":"2013","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.breast.2022.04.003_bib17","doi-asserted-by":"crossref","first-page":"547","DOI":"10.7326\/M18-2147","article-title":"Screening for breast cancer in average-risk women: a guidance statement from the American College of Physicians","volume":"170","author":"Qaseem","year":"2019","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.breast.2022.04.003_bib18","first-page":"452","article-title":"Breast cancer screening and Diagnosis,Version 1.2019, NCCN clinical practice guidelines in Oncology","volume":"18","author":"William","year":"2020","journal-title":"J Natl Compr Cancer Netw"},{"issue":"11S","key":"10.1016\/j.breast.2022.04.003_bib19","doi-asserted-by":"crossref","first-page":"S383","DOI":"10.1016\/j.jacr.2017.08.044","article-title":"ACR appropriateness Criteria\u00ae breast cancer screening","volume":"14","author":"Mainiero","year":"2017","journal-title":"J Am Coll Radiol"},{"issue":"3 Pt A","key":"10.1016\/j.breast.2022.04.003_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jacr.2017.11.034","article-title":"Breast cancer screening in women at higher-than-average risk: recommendations from the ACR","volume":"15","author":"Monticciolo","year":"2018","journal-title":"J Am Coll Radiol"},{"issue":"9","key":"10.1016\/j.breast.2022.04.003_bib21","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jacr.2017.06.001","article-title":"Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging","volume":"14","author":"Monticciolo","year":"2017","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"10.1016\/j.breast.2022.04.003_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jacr.2009.09.022","article-title":"Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer","volume":"7","author":"Lee","year":"2010","journal-title":"J Am Coll Radiol"},{"issue":"15","key":"10.1016\/j.breast.2022.04.003_bib23","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1001\/jama.2015.12783","article-title":"Breast cancer screening for women at average risk: 2015 guideline update from the American cancer society","volume":"314","author":"Oeffinger","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.breast.2022.04.003_bib24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/AOG.0000000000002158","article-title":"Practice bulletin number 179: breast cancer risk assessment and screening in average-risk women","volume":"130","year":"2017","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.breast.2022.04.003_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.7326\/M19-2125","article-title":"Breast cancer screening and diagnosis: a synopsis of the European breast guidelines","volume":"172","author":"Sch\u00fcnemann","year":"2020","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.breast.2022.04.003_bib26","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.ejca.2010.02.015","article-title":"Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group","volume":"46","author":"Sardanelli","year":"2010","journal-title":"Eur J Cancer"},{"issue":"49","key":"10.1016\/j.breast.2022.04.003_bib27","doi-asserted-by":"crossref","first-page":"E1441","DOI":"10.1503\/cmaj.180463","article-title":"Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer","volume":"190","author":"Klarenbach","year":"2018","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"18","key":"10.1016\/j.breast.2022.04.003_bib28","first-page":"316","article-title":"The screening, diagnosis, treatment, and follow-up of breast cancer","volume":"115","author":"W\u00f6ckel","year":"2018","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.breast.2022.04.003_bib29","unstructured":"Cancer Australia. Early detection of breast cancer. Available at:https:\/\/www.canceraustralia.gov.au\/resources\/position-statements\/early-detection-breast-cancer. [accessed 2021-03-01]."},{"key":"10.1016\/j.breast.2022.04.003_bib30","unstructured":"Ministry of Health Singapore. Cancer screening, MOH Clinical Practice Guidelines. Available at:https:\/\/www.moh.gov.sg\/docs\/librariesprovider4\/guidelines\/cpg_cancer-screening.pdf. [accessed 2021-03-01]."},{"key":"10.1016\/j.breast.2022.04.003_bib31","unstructured":"Ministry of Health of Malaysia. Management of Breast Cancer (3rd Edition). Available at: https:\/\/www2.moh.gov.my\/moh\/resources\/Penerbitan\/CPG\/Kanser\/Breast%20Cancer\/CPG_Management_of_Breast_Cancer_(Third_Edition)_130720.pdf. [accessed 2021-03-01]."},{"issue":"4","key":"10.1016\/j.breast.2022.04.003_bib32","first-page":"357","article-title":"China guideline for the screening and early detection of female breast cancer(2021, Beijing)","volume":"43","author":"He","year":"2021","journal-title":"Zhonghua Zhongliu Zazhi"},{"issue":"3","key":"10.1016\/j.breast.2022.04.003_bib33","first-page":"298","article-title":"Recommendations on prevention and screening for breast cancer in Hong Kong","volume":"24","author":"Lam","year":"2018","journal-title":"Hong Kong Med J"},{"issue":"6","key":"10.1016\/j.breast.2022.04.003_bib34","article-title":"Guidelines for early detection of breast cancer in Brazil. II - new national recommendations, main evidence, and controversies","volume":"34","author":"Migowski","year":"2018","journal-title":"Cad Sa\u00fade P\u00fablica"},{"issue":"4","key":"10.1016\/j.breast.2022.04.003_bib35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1590\/0100-3984.2017-0069","article-title":"Breast cancer screening: updated recommendations of the Brazilian College of Radiology and diagnostic imaging, Brazilian breast disease society, and Brazilian federation of gynecological and obstetrical Associations","volume":"50","author":"Urban","year":"2017","journal-title":"Radiol Bras"},{"issue":"Suppl 2","key":"10.1016\/j.breast.2022.04.003_bib36","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.breast.2011.01.012","article-title":"Establishing an evidence-base for breast cancer control in developing countries","volume":"20","author":"Lodge","year":"2011","journal-title":"Breast"},{"issue":"6","key":"10.1016\/j.breast.2022.04.003_bib37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1634\/theoncologist.2015-0429","article-title":"Breast cancer in sub-saharan africa: challenges and opportunities to reduce mortality","volume":"21","author":"Pace","year":"2016","journal-title":"Oncol"},{"key":"10.1016\/j.breast.2022.04.003_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12883-015-0501-3","article-title":"Methodological quality of guidelines for management of Lyme neuroborreliosis","volume":"15","author":"Dersch","year":"2015","journal-title":"BMC Neurol"},{"issue":"3","key":"10.1016\/j.breast.2022.04.003_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174831","article-title":"Guideline appraisal with AGREE II: systematic review of the current evidence on how users handle the 2 overall assessments","volume":"12","author":"Hoffmann-E\u00dfer","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.breast.2022.04.003_bib41","first-page":"438","article-title":"Breast cancer statistics","volume":"69","author":"DeSantis","year":"2019","journal-title":"CA Cancer J Clin 2019"},{"issue":"13","key":"10.1016\/j.breast.2022.04.003_bib42","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1001\/jama.2014.1398","article-title":"A systematic assessment of benefits and risks to guide breast cancer screening decisions","volume":"311","author":"Pace","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2022.04.003_bib43","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1002\/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H","article-title":"Efficacy of breast cancer screening by age new results from the Swedish two-county trial","volume":"75","author":"Tabar","year":"1995","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.breast.2022.04.003_bib45","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s12282-020-01139-3","article-title":"Annual report of the Japanese breast cancer registry for 2017","volume":"27","author":"Hayashi","year":"2020","journal-title":"Breast Cancer"},{"issue":"2","key":"10.1016\/j.breast.2022.04.003_bib46","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4143\/crt.2020.206","article-title":"Community of population-based regional cancer registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017","volume":"52","author":"Hong","year":"2020","journal-title":"Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.breast.2022.04.003_bib47","first-page":"1459","article-title":"Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years","volume":"147","author":"Miller","year":"1992","journal-title":"CMAJ (Can Med Assoc J)"},{"key":"10.1016\/j.breast.2022.04.003_bib48","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/cncr.29975","article-title":"Updated results of the gothenburg trial of mammographic screening","volume":"122","author":"Bjurstam","year":"2016","journal-title":"Cancer"},{"issue":"9310","key":"10.1016\/j.breast.2022.04.003_bib49","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0140-6736(02)08020-0","article-title":"Long-term effects of mammography screening: updated overview of the Swedish randomised trials","volume":"359","author":"Nystr\u00f6m","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.breast.2022.04.003_bib50","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2214\/AJR.17.18705","article-title":"Screening for breast cancer in women age 75 Years and older","volume":"210","author":"Lee","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"24","key":"10.1016\/j.breast.2022.04.003_bib51","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1056\/NEJMsr1504363","article-title":"International Agency for Research on Cancer Handbook Working Group. Breast-cancer screening--viewpoint of the IARC Working Group","volume":"372","author":"Lauby-Secretan","year":"2015","journal-title":"N Engl J Med"},{"issue":"8 Suppl","key":"10.1016\/j.breast.2022.04.003_bib52","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1002\/cncr.23842","article-title":"Guideline implementation for breast healthcare in low- and middle-income countries: early detection resource allocation","volume":"113","author":"Yip","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2022.04.003_bib53","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1148\/rg.352140276","article-title":"Invited commentary: the breast density dilemma\u2013challenges, lessons, and future directions","volume":"35","author":"Butler","year":"2015","journal-title":"Radiographics"},{"issue":"6","key":"10.1016\/j.breast.2022.04.003_bib54","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3961\/jpmph.16.054","article-title":"Breast density and risk of breast cancer in asian women: a meta-analysis of observational studies","volume":"49","author":"Bae","year":"2016","journal-title":"J Prev Med Public Health"},{"issue":"10016","key":"10.1016\/j.breast.2022.04.003_bib55","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(15)00774-6","article-title":"Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial","volume":"387","author":"Ohuchi","year":"2016","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.breast.2022.04.003_bib56","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1148\/radiol.2021203134","article-title":"Addition of screening breast US to digital mammography and digital breast tomosynthesis for breast cancer screening in women at average-risk","volume":"298","author":"Yi","year":"2021","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.breast.2022.04.003_bib57","first-page":"891","article-title":"Cost-effectiveness of optimized ultrasound-based breast cancer screening for Chinese rural women in 2015","volume":"28","author":"Ma","year":"2019","journal-title":"China Cancer"},{"issue":"4","key":"10.1016\/j.breast.2022.04.003_bib58","first-page":"497","article-title":"Breast ultrasound optimization process analysis based on breast cancer screening for 1 501 753 rural women in China","volume":"43","author":"Ma","year":"2021","journal-title":"Zhonghua zhong liu za zhi [Chinese journal of oncology]"},{"issue":"1","key":"10.1016\/j.breast.2022.04.003_bib59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13058-018-0947-5","article-title":"Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis","volume":"20","author":"Wang","year":"2018","journal-title":"Breast Cancer Res"},{"issue":"5","key":"10.1016\/j.breast.2022.04.003_bib60","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s41416-020-0937-0","article-title":"Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations","volume":"123","author":"Ming","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2022.04.003_bib61","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fonc.2019.00286","article-title":"Ultrasound for breast cancer screening in high-risk women: results from a population-based cancer screening program in China","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol"},{"issue":"3","key":"10.1016\/j.breast.2022.04.003_bib62","first-page":"199","article-title":"Timely follow-up of positive cancer screening results: a systematic review and recommendations from the PROSPR Consortium","volume":"68","author":"Doubeni","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.breast.2022.04.003_bib63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1186\/s12885-021-08100-3","article-title":"Delayed or failure to follow-up abnormal breast cancer screening mammograms in primary care: a systematic review","volume":"21","author":"Reece","year":"2021","journal-title":"BMC Cancer"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622000765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977622000765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:45:27Z","timestamp":1760777127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977622000765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":60,"alternative-id":["S0960977622000765"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2022.04.003","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global guidelines for breast cancer screening: A systematic review","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2022.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}